Australia markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.95+0.69 (+1.63%)
At close: 04:00PM EDT
43.06 +0.11 (+0.26%)
After hours: 07:38PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-339,069
-325,104
-277,417
-173,910
-45,574
Depreciation & amortisation
2,143
1,667
765
490
349
Stock-based compensation
101,601
94,534
72,965
38,444
10,034
Change in working capital
-11,134
-583
38,103
5,118
1,346
Accounts receivable
-15,529
-5,930
0
0
-
Inventory
-5,216
-3,103
0
0
-
Accounts payable
172
-196
4,168
2,074
-1,304
Other working capital
-244,892
-230,180
-171,759
-129,893
-32,833
Other non-cash items
1,767
1,653
1,131
993
1,049
Net cash provided by operating activities
-239,907
-222,795
-161,563
-127,877
-32,191
Cash flows from investing activities
Investments in property, plant and equipment
-4,985
-7,385
-10,196
-2,016
-642
Acquisitions, net
-
-2,800
-4,200
0
-
Purchases of investments
-581,218
-575,724
-481,050
-305,423
-442,690
Sales/maturities of investments
552,051
620,663
279,849
391,031
28,000
Net cash used for investing activities
-42,387
34,754
-215,597
83,592
-418,832
Cash flows from financing activities
Common stock issued
-
299,300
340,066
0
269,592
Common stock repurchased
-
-2,800
-1,341
0
0
Net cash used provided by (used for) financing activities
297,935
296,639
340,702
1,157
270,485
Net change in cash
15,641
108,598
-36,458
-43,128
-180,538
Cash at beginning of period
103,006
68,068
104,526
147,654
328,192
Cash at end of period
118,647
176,666
68,068
104,526
147,654
Free cash flow
Operating cash flow
-239,907
-222,795
-161,563
-127,877
-32,191
Capital expenditure
-4,985
-7,385
-10,196
-2,016
-642
Free cash flow
-244,892
-230,180
-171,759
-129,893
-32,833